Sammendrag kun tilgjengelig på engelsk:
The Norwegian Institute for Alcohol and Drug Research (SIRUS) is the Norwegian Focal Point for the European Monitoring Centre for Drugs and Drug Addiction– EMCDDA. As an important part of its duties SIRUS has since 2001 produced annual reports on the national drug situation for use for the EMCDDA’s purposes.
This report was prepared in accordance with guidelines that are common to all the 26 member states in the EMCDDA.
As in previous years, this report was based on textual contributions and data from central public institutions in Norway and other players in the drugs and alcohol field. The text and data have been reviewed and verified by an internal reference group in SIRUS.
This is a report from the Norwegian Institute for Alcohol and Drug Research (SIRUS). SIRUS was incorporated into the Norwegian Institute of Public Health in January 2016.